 Home > Medical News >

Medical Research Articles

FDA has granted fast-track eligibility to INT230-6 for treatment of patients with triple-negative breast cancer

 Time of Update: 2020-06-10

types cell phones cholinesterase inhibitors drugs breast cancer biomarkers lidocaine 1 injection clinical translation

recently, The U.S FDA (http:// has granted fast-track eligibility for programs for patients with recurrent or metastatic triple-negative breast cancer (TNBC) who have previously received at least
FDA accepts new drug application for Gene Tektronix XOFLUZA ™

 Time of Update: 2020-06-10

necessary acid drug definition 1 2 butadiene roche daratumumab mechanism action

recently, Roche Group member GeneTec announced that the U.S Food medicines (http:// Administration ( FDA (http:// ) has accepted the xOFLUZa ™ (baloxavir marboxil) supplement new drug (http://
FDA accepts application for license to supplementary biologics from gene Tecentriq

 Time of Update: 2020-06-10

parainfluenza 3 treatment 10 colognes 2019 caspase 3 antibody 1 3 generator checkers 2 5

today, Roche's Genentech company, (http:// announced that the u.S FDA (http:// has accepted the company's application for a supplementary biologic license (sBLAB) for Tecentriq (sBLAb) for use
MGB's research new drug application for MGB-BP-3, lead candidate drug, approved by FDA and Health Canada

 Time of Update: 2020-06-10

ind clinical trial strain test 1 3 propanesultone plastic number 1 what 1 gram

recently, MGB Biopharma Biopharma Bio Pharmaceutical (http:// company (http:// announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) and Health Canada has approved i
2 Phase III clinical studies treating acursion synodi, oral anti-inflammatory drug Olumiant (baricitinib), reach the main endpoint

 Time of Update: 2020-06-10

herpes 1 2 new release foams chamomile anti inflammatory natural anti inflammatory phase 2 metabolism

acursion (AD) is a serious chronic inflammatory skin disease characterized by severe itching, noticeable eczema-like changes and dry skin recently, U.S Pharmaceutical (http:// giant Eli Lilly an
NMPA grants Sumitomo Pharmaceuticals atypical antipsychotic drug Rosuda ® imported drug license for the treatment of schizophrenic patients

 Time of Update: 2020-06-10

new world cleaners dopamine deficiency treatment xanax drug effects antipsychotic drugs name histamine receptors

recently, s http:// umitomo Dainippon , a Japanese drug maker, announced that The Regulatory Authority (NMPA), China's national drug (http:// has granted a license on January 24, 2019 to the atyp
Gelesis announces FDA approval for prescription drug PLENITY

 Time of Update: 2020-06-10

devil's breath drug effects motegrity side effects hydroquinone 2 percent niacin drug fda guidelines food

obesity is a disease that increases the risk of more than 30 diseases, such as diabetes, non-alcoholic fatty liver disease (NAFLD) According to the survey, 70 to 80 percent of obese patients have NA
The drug golodirsen, which treats Duchenne's muscular dystrophy, was accepted by the FDA and qualified for priority review

 Time of Update: 2020-06-10

pending fda approvals biological safety cabinet drug test dmt verification validation fda fda dmf

progressive muscular dMD is an X-linked genetic disease caused by mutations in the genes encoded on the X chromosome that encode antimuscular hytrophin (dystrophin) today, Sarepta Company (http:/
New eye mask with soluble needles can be used to treat eye diseases for continuous administration

 Time of Update: 2020-06-10

all therapy blood type antibodies led eye mask skin spot treatment build shade structure

recently, a joint team of Singapore institutions has developed an eye mask with soluble needles this double-layered eye mask can be used to treat eye diseases and can be used for continuous adminis
Phase III clinical study of Cinda Bio-Innovative Oncology Drug Damerschu ® (SindyLi Monoantigen) completes first patient administration

 Time of Update: 2020-06-10

esophageal cancer prevention name pk pd studies doxycycline mono 100 chemotherapy

today (January 17), Cinda Bio Pharmaceutical (http:// (Hong Kong Stock Exchange Code: 01801) announced that the Innovative Oncology Drug (http:// Dabershu ® (Recombinant Whole Human Source Ant
New Base and Acceleron Pharmaceuticals submit to FDA application for license to biologics for experimental red blood cell maturant luspatercept

 Time of Update: 2020-06-10

data normalization example stage 1 cte food stock images new world history low iron eyes

recently, bio pharmaceutical (http:// giants Newgene and Acceleron Pharmaceuticals (http:// announced that they have submitted an experimental red blood cell maturation agent luspatercept to t
State Drug Administration approves application for registration of import of Pago films

 Time of Update: 2020-06-10

rufinol drug maalox drug effexor drug interactions darvon drug pantoprazole drug

pulmonary arterial hypertension is a disease of abnormally elevated blood pressure in the pulmonary arteries caused by known or unknown causes, characterized by vascular spasms, endometrium hyperpla
FDA grants Acurx's experimental antibiotic ACX-362E fast-track eligibility to treat Clostridium difficile infection

 Time of Update: 2020-06-10

new dna cml blast phase product development careers class ii fast

recently, Acurx Pharmaceutical sin (http:// (http:// announced that the Administration of the food and drugs (http:// ( FDA (http:// ) has granted the experimental antibiotic ACX-362E fast
Phase III clinical study of Maruho's nemolizumab for treatment of atopic dermatitis-related itching reached its main endpoint

 Time of Update: 2020-06-10

labetalol half life therapeutic monoclonal antibodies active pharmaceutical ingredient cypionate half life acetylcholine receptor binding antibody

recently, Maruho Company (http:// announced that phase III clinical study conducted in Japan to assess the treatment of atopic dermatitis (AD, special type of eczema)-related itching has reached
CHMP recommends approval of the new base is based on the triple therapy of Revlidomide (Lenalidomide, Tonala)

 Time of Update: 2020-06-10

immune globulin therapy make acid drug 3 cell batteries stem cell supplements new drug approvals

recently, Celgene company (http:// announced that the European EMA human medicine (http:// product (http:// Committee (CHMP) recommended that the company's triple therapy based on Revlimid (
A brief application for a new drug for Lochatan potassium tablets filed by Haizheng Pharmaceuticals to the U.S. FDA has been approved

 Time of Update: 2020-06-10

cilostazol drug class industrial chemical company rc tablets natural potassium binders lactase enzyme tablets

recently, Haizheng Pharmaceuticals announced that the holding company (http:// Haizheng Pharmaceutical (Hangzhou) Co., Ltd ("Haizheng Hangzhou Company") received a notice from the U.S Food Medic
FDA grants Imbrium Therapeutics experimental drug etoposide toniribate orphan drug

 Time of Update: 2020-06-10

farxiga drug class omega 3 function dna study refractory phase data mechanics

recently, Imbrium 's (http:// announced that the (http:// Administration ( FDA http:// ) has granted the experimental drug etoposide toniribate orphan drug (ODD), a new topological isolic enz
FDA approves Circassia's Duaklir Pressair for maintenance therapy for patients with chronic obstructive pulmonary disease

 Time of Update: 2020-06-10

nexplanon fda approved therapy statin brand names disease breath

chronic obstructive pulmonary disease (COPD) is a progressive disease that is mainly associated with smoking, air pollution or occupational contact, which causes breathing difficulties and an increa
Bayer's new prostate cancer drug Xofigo's listing application is officially accepted by CDE

 Time of Update: 2020-06-10

customer service sales global attribution zantac drug class fda drug database global warming presentation

recently, Bayer 's application for the listing of the new drug (http:// Xofigo (223Ra) was officially accepted by CDE Xofigo Xofigo was first approved by the FDA (http:// on May 15, 2013 to t
FDA approves new drug, Ravulizumab, to be marketed for PNH

 Time of Update: 2020-06-10

remove lead body adp receptor inhibitors anemia natural treatment cell death disease glargine long acting

PNH is a rare blood disease characterized by complement-mediated red blood cell destruction (hemolytic) that can cause a wide range of debilitating symptoms and complications, such as hemolytic, ven

Go to Page

Medical Research Articles

FDA has granted fast-track eligibility to INT230-6 for treatment of patients with triple-negative breast cancer

FDA accepts new drug application for Gene Tektronix XOFLUZA ™

FDA accepts application for license to supplementary biologics from gene Tecentriq

MGB's research new drug application for MGB-BP-3, lead candidate drug, approved by FDA and Health Canada

2 Phase III clinical studies treating acursion synodi, oral anti-inflammatory drug Olumiant (baricitinib), reach the main endpoint

NMPA grants Sumitomo Pharmaceuticals atypical antipsychotic drug Rosuda ® imported drug license for the treatment of schizophrenic patients

Gelesis announces FDA approval for prescription drug PLENITY

The drug golodirsen, which treats Duchenne's muscular dystrophy, was accepted by the FDA and qualified for priority review

New eye mask with soluble needles can be used to treat eye diseases for continuous administration

Phase III clinical study of Cinda Bio-Innovative Oncology Drug Damerschu ® (SindyLi Monoantigen) completes first patient administration

New Base and Acceleron Pharmaceuticals submit to FDA application for license to biologics for experimental red blood cell maturant luspatercept

State Drug Administration approves application for registration of import of Pago films

FDA grants Acurx's experimental antibiotic ACX-362E fast-track eligibility to treat Clostridium difficile infection

Phase III clinical study of Maruho's nemolizumab for treatment of atopic dermatitis-related itching reached its main endpoint

CHMP recommends approval of the new base is based on the triple therapy of Revlidomide (Lenalidomide, Tonala)

A brief application for a new drug for Lochatan potassium tablets filed by Haizheng Pharmaceuticals to the U.S. FDA has been approved

FDA grants Imbrium Therapeutics experimental drug etoposide toniribate orphan drug

FDA approves Circassia's Duaklir Pressair for maintenance therapy for patients with chronic obstructive pulmonary disease

Bayer's new prostate cancer drug Xofigo's listing application is officially accepted by CDE

FDA approves new drug, Ravulizumab, to be marketed for PNH